seen from Netherlands
seen from Russia
seen from United States
seen from Malaysia
seen from United States
seen from Japan
seen from Malaysia
seen from Ireland
seen from Ukraine
seen from Russia
seen from Sweden
seen from Sweden
seen from China
seen from China
seen from Japan
seen from Brazil
seen from Australia
seen from Sweden
seen from Russia
seen from Ireland
Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Name Transcript
Comply with Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Name November 4, 2025 4:30 PM EST Firm Members Anish Bhatnagar – Chairman, President, CEO & COOMeredith Manning – Chief Industrial OfficerJames MacKaness – CFO & Compliance Officer Convention Name Members Brian Ritchie – Lifesci Advisors, LLCKyuwon Choi – Goldman Sachs Group, Inc., Analysis DivisionTyler Van Buren – TD Cowen,…
(Nasdaq:SLNO) Soleno Therapeutics Inc Analysts Are
(Nasdaq:SLNO) Soleno Therapeutics Inc Analysts Are
Soleno Therapeutics Inc (Nasdaq:SLNO)
June 22nd, 2018
Soleno Therapeutics Inc closed Friday up 33.05%, a $0.77 increase to close on $3.10. The stock continues to trade well at 135% of its 52 week low of $1.32. In addition to finishing higher, trading volumes were solid at 22,690% of normal which can indicate investors see opportunities.
SLNO outperformed the rest of the Healthcare sector…
View On WordPress
